Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
Clinical trial NCT01678976 · COMPLETED
Trial details
- NCT number
- NCT01678976
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2002-04-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.